{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:48:32Z","timestamp":1780490912289,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Recent improvements in coronary stent design have focussed on thinner struts, different alloys and architecture, more biocompatible polymers, and shorter drug absorption times. This study evaluates safety and efficacy of a newer generation thin-strut cobalt chromium sirolimus-eluting coronary stent (SES, Ultimaster) in comparison with a second-generation thicker strut stainless steel biolimus-eluting stent (BES, Nobori) in percutaneous coronary intervention (PCI) practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A propensity score analysis was performed to adjust for differences in baseline characteristics of 8137 SES patients and 2738 BES patients of two PCI registries (e-Ultimaster and NOBORI 2). An independent clinical event committee adjudicated all endpoint-related adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The use of SES, as compared with BES was associated with a significantly lower rate of myocardial infarction (MI) (1.2% vs 2.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0006) and target vessel-related MI (1.1% vs 1.8%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002) at 1 year. One-year composite endpoints of all predefined endpoints were lower in patients undergoing SES implantation (target lesion failure: 3.2% vs 4.1%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03, target vessel failure: 3.7% vs 5.0%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003, patient-oriented composite endpoint 5.7% vs 6.8%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03). No significant differences between SES and BES were observed in all-cause death (2.0% vs 1.6%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.19), cardiac death (1.2% vs 1.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.76) or stent thrombosis (0.6% vs 0.8%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.43).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings suggest an improved clinical safety and efficacy of a newer generation thin-strut SES as compared with a second-generation thicker strut BES.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000958","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T11:33:32Z","timestamp":1602761612000},"page":"391-396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries"],"prefix":"10.1097","volume":"32","author":[{"given":"Selina","family":"Vlieger","sequence":"first","affiliation":[{"name":"Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian B.","family":"Danzi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Ospedale Santa Corona, Pietra Ligure, Savona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Kauer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit M.","family":"Oemrawsingh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Stojkovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Center of Serbia, Belgrade, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.J.","family":"IJsselmuiden","sequence":"additional","affiliation":[{"name":"Amphia Ziekenhuis, Breda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Routledge","sequence":"additional","affiliation":[{"name":"Worcestershire Acute Hospitals NHS Trust, Worcester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peep","family":"Laanmets","sequence":"additional","affiliation":[{"name":"North-Estonia Medical Center, Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux Universitaires de Gen\u00e8ve, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Fr\u00f6bert","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Baello","sequence":"additional","affiliation":[{"name":"Hospital General Castell\u00f3n, Castellon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Wlodarczak","sequence":"additional","affiliation":[{"name":"Miedziowe Centrum Zdrowia, Lubin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Puentes","sequence":"additional","affiliation":[{"name":"Hospital San Juan de Dios, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed","family":"Polad","sequence":"additional","affiliation":[{"name":"Jeroen Bosch Hospital, \u2019s-Hertogenbosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hildick-Smith","sequence":"additional","affiliation":[{"name":"Sussex Cardiac Centre, Brighton & Sussex University Hospitals, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2018:8:2","article-title":"The newest generation of drug-eluting stents and beyond.","volume":"13","author":"Lee","year":"2018","journal-title":"Eur Cardiol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer generation ultra-thin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: a meta-analysis of randomized trials.","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/eurheartj\/ehr126","article-title":"Evaluating the \u2018all-comers\u2019 design: a comparison of participants in two \u2018all-comers\u2019 PCI trials with non-participants.","volume":"32","author":"de Boer","year":"2011","journal-title":"Eur Heart J"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4244\/EIJV8I1A17","article-title":"Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.","volume":"8","author":"Danzi","year":"2012","journal-title":"Eurointervention"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"e1490","DOI":"10.3390\/ijms17091490","article-title":"The ultimaster biodegradable-polymer sirolimus-eluting stent: an updated review of clinical evidence.","volume":"17","author":"Chisari","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R9-20250729","first-page":"599","article-title":"Nobori\u2122 drug eluting stent system: clinical evidence update.","volume":"58","author":"Danzi","year":"2010","journal-title":"Minerva Cardioangiol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4244\/EIJ-D-17-00731","article-title":"Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).","volume":"13","author":"Jensen","year":"2018","journal-title":"Eurointervention"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents.","volume":"72","author":"Kandzari","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"e007331","DOI":"10.1161\/CIRCINTERVENTIONS.118.007331","article-title":"Subgroup analysis comparing ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in acute coronary syndrome patients.","volume":"11","author":"Roguin","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4244\/EIJ-D-16-00179","article-title":"Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial.","volume":"12","author":"Kang","year":"2017","journal-title":"Eurointervention"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(17)33103-3","article-title":"A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.","volume":"391","author":"de Winter","year":"2018","journal-title":"Lancet"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ehjqcco\/qcy036","article-title":"A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents.","volume":"5","author":"Mridha","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/eurheartj\/ehs036","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction.","volume":"33","author":"Kalesan","year":"2012","journal-title":"Eur Heart J"},{"key":"R18-20250729","first-page":"33","article-title":"Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating.","volume":"9","author":"Saito","year":"2016","journal-title":"Med Devices (Auckl)"},{"key":"R19-20250729","first-page":"e004801","article-title":"Serial assessment of strut coverage of biodegradable polymer drug-eluting stent at 1, 2, and 3 months after stent implantation by optical frequency domain imaging: the discovery 1to3 study (evaluation with ofdi of strut coverage of terumo new drug eluting stent with biodegradable polymer at 1, 2, and 3 months).","volume":"10","author":"Chevalier","year":"2017","journal-title":"Circulation"},{"key":"R20-20250729","first-page":"1810","article-title":"Early strut coverage in patients receiving drug-eluting stents and its implications for dual antiplatelet therapy: a randomized trial.","volume":"11","author":"Lee","year":"2018","journal-title":"JACC"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.116.022061","article-title":"Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention.","volume":"134","author":"Kirtane","year":"2016","journal-title":"Circulation"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:08:27Z","timestamp":1753812507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000958","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,20]]}}}